S.Res. 104: A resolution designating February 27, 2025, as "Rare Disease Day".

Introduced Feb 27, 20256 cosponsors

Sponsor

John Barrasso

John Barrasso

Republican · WY

Bill Progress

IntroducedFeb 27
Committee 
Pass SenateFeb 27
Pass House 
Signed 
Law 

Latest Action · Feb 27, 2025

1/3

Passed the Senate, received in House

Senate spotlights rare disease urgency

Why it matters

The Senate approved this on Rare Disease Day itself, underscoring growing attention to millions of Americans who still lack diagnoses, specialists, or approved treatments.

In practical terms, this is mostly an awareness measure. It recognizes the importance of better public understanding, earlier and more accurate diagnosis, and stronger national and global research efforts. That may sound symbolic, but these resolutions can help advocacy groups, researchers, and patients build momentum for future legislation, funding, and regulatory action.

What does S.Res. 104 do?

1

Names February 27 as Rare Disease Day

Officially designates February 27, 2025, as "Rare Disease Day" in the Senate.

2

Highlights the scale of rare disease

States that more than 30 million people in the United States live with at least one of more than 10,000 known rare diseases or disorders.

3

Calls attention to treatment gaps

Notes that although many orphan drugs have been approved, about 95 percent of rare diseases still do not have an FDA-approved treatment.

4

Supports earlier and accurate diagnosis

Recognizes the importance of helping patients get diagnosed sooner and more accurately, which is a major problem in rare disease care.

5

Backs research and innovation

Expresses support for national and global research efforts to develop effective treatments, diagnostic tools, and cures.

6

Acknowledges existing federal efforts

Points to the Orphan Drug Act, FDA rare disease work, and NIH research as important parts of the response to rare diseases.

Who benefits from S.Res. 104?

People living with rare diseases

They gain visibility for their medical needs and stronger public recognition of the barriers they face in diagnosis, treatment, and care.

Families and caregivers

The resolution validates the financial and emotional strain families often face and helps spotlight the need for better support systems.

Rare disease advocacy organizations

These groups can use the Senate’s statement of support to push for future policy changes, research funding, and public education.

Researchers and drug developers

The measure reinforces political support for rare disease research and for efforts to develop new tests, drugs, and cures.

Who is affected by S.Res. 104?

Children with rare diseases

The resolution specifically notes that children make up a significant share of rare disease patients, highlighting their need for faster diagnosis and treatment.

Doctors and specialty treatment centers

It draws attention to the shortage of expertise and the difficulty patients face in finding providers familiar with rare conditions.

Federal health agencies

The FDA and NIH are recognized as key players in rare disease research and treatment development, adding pressure to continue that work.

Patients facing high treatment costs

The resolution acknowledges that paying for life-altering or lifesaving treatments can be a major challenge for patients and families.

SRES104 Legislative Journey

1 actions

Floor Action

Feb 27, 2025

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S1434; text: CR S1433)

About the Sponsor

John Barrasso

John Barrasso

Republican, WY · 19 years in Congress

Committees: Energy and Natural Resources, Foreign Relations, Finance

View full profile →

Cosponsors (6)

No new cosponsors in 380 days — momentum stalled

This bill has 6 cosponsors: 3 Democrats, 3 Republicans, reflecting bipartisan support. Cosponsors represent 6 states: Connecticut, Kansas, Minnesota, and 3 more.

3Democrats3Republicans·6 statesBipartisan

S.Res. 104 Quick Facts

Cosponsors
6
Richard Blumenthal
Amy Klobuchar
Roger Marshall
Tim Scott
Roger Wicker
+1 more
Chamber
Senate
Policy
Health
Introduced
Feb 27, 2025

Passed the Senate, received in House

Feb 27, 2025

Constituent Resources

Find your legislators on S.Res. 104
Get notified when this bill moves

S.Res. 104 Bill Text

Designating February 27, 2025, as “Rare Disease Day”.

Source: U.S. Government Publishing Office

Bill Alerts

Get notified when S.Res. 104 moves

Committee votes, floor action, cosponsor changes — straight to your inbox.

Bill alerts + Legisletter's monthly briefing. Unsubscribe anytime.

Health Bills

9 related bills we're tracking

View all
H.R. 1262

Give Kids a Chance Act of 2025

Michael McCaul
Michael McCaulR-TX
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+309
313 cosponsors

Motion to reconsider laid on the table Agreed to without objection.

Dec 1, 2025

HouseHealth
H.R. 3514

Improving Seniors’ Timely Access to Care Act of 2025

Mike Kelly
Mike KellyR-PA
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+254
258 cosponsors
+4 this month

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

May 20, 2025

HouseHealth
H.R. 4206Surging+10

CONNECT for Health Act of 2025

Mike Thompson
Mike ThompsonD-CA
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+223
227 cosponsors
+10 this month

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jun 26, 2025

HouseHealth
H.R. 999

Right to Contraception Act

Lizzie Fletcher
Lizzie FletcherD-TX
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+202
206 cosponsors
+1 this month

Referred to the House Committee on Energy and Commerce.

Feb 5, 2025

HouseHealth
H.R. 879

Medicare Patient Access and Practice Stabilization Act of 2025

Gregory Murphy
Gregory MurphyR-NC
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+191
195 cosponsors
+1 this month

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jan 31, 2025

HouseHealth
H.R. 539

Chiropractic Medicare Coverage Modernization Act of 2025

W. Steube
W. SteubeR-FL
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+148
152 cosponsors
+2 this month

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jan 16, 2025

HouseHealth
H.R. 5434Gaining+8

988 LGBTQ+ Youth Access Act of 2025

Raja Krishnamoorthi
Raja KrishnamoorthiD-IL
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+140
144 cosponsors
+8 this month

Referred to the House Committee on Energy and Commerce.

Sep 17, 2025

HouseHealth
H.R. 3277Gaining+7

Ensuring Lasting Smiles Act

Neal Dunn
Neal DunnR-FL
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+130
134 cosponsors
+7 this month

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

May 8, 2025

HouseHealth
H.R. 3757Gaining+5

Pride In Mental Health Act of 2025

Sharice Davids
Sharice DavidsD-KS
Cosponsor
Cosponsor
Cosponsor
Cosponsor
+128
132 cosponsors
+5 this month

Referred to the House Committee on Energy and Commerce.

Jun 5, 2025

HouseHealth

Trending Right Now

Bills gaining momentum across Congress

Tracking Health in Congress? Monitor bills, track cosponsor momentum, and launch advocacy campaigns — all from one advocacy platform.